Please use this identifier to cite or link to this item:
http://repository.tma.uz/xmlui/handle/1/5157
Title: | Gout Therapy With Reduced Kidney Function |
Authors: | Mirzaeva Gulchehra Fayzullaevna Jabbarov Ozimbay Otakhanovich Buvamukhamedova Nasiba Tokhirovna Rakhmatov Avaz Mamatovich Jumanazarov Sultanbay Bakhadirovich |
Keywords: | gout, kidney disease, febuxostat,allopurinol |
Issue Date: | 2022 |
Publisher: | Испания |
Abstract: | Gout is often combined with kidney disease. The pathology itself and concomitant hyperuricemia are considered as independent nephrotoxic factors. Urate-reducing therapy of gout can level the pathogenic effect of uric acid, preventing the development and progression of chronic kidney disease. However, in patients with reduced kidney function, its choice should be more careful. It is important to select not only the optimal urate-reducing drug, but also its dosing regimen. In this population, it is also difficult to set treatment goals and methods to evaluate its effectiveness. Xanthine oxidase inhibitors appear to be the most promising in the presence of renal pathology. |
URI: | http://repository.tma.uz/xmlui/handle/1/5157 |
Appears in Collections: | Thesis, Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1.6.1. Mирзаева Г.П..pdf | 722.75 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.